FXIa-IN-7 is primarily used in research settings to study the role of Factor XIa in blood coagulation. It serves as a selective inhibitor, helping scientists understand the mechanisms of thrombosis and hemostasis. This compound is particularly valuable in developing potential therapeutic agents for conditions like deep vein thrombosis, stroke, and other clotting disorders. By targeting Factor XIa, it offers a promising approach to reduce the risk of bleeding complications compared to traditional anticoagulants. Additionally, it aids in exploring safer and more effective treatments for patients with cardiovascular diseases.